Access portals, or ports, provide a convenient method to repeatedly deliver medicants to remote areas of the body without utilizing surgical procedures. The port is totally implantable within the body, and permits the infusion of medications, parenteral solutions, blood products, and other fluids. The port may also be used for blood sampling.
Known ports typically include a chamber accessible through a self-sealing septum. Septums of the prior art vary in shape, from a wafer-like cylindrical block of silicone to a pre-molded septum of U.S. Pat. No. 4,802,885 to Weeks et al. The pre-molded septum of U.S. Pat. No. 4,802,885 includes opposed convex surfaces and a peripheral ledge.
In common practice, a caregiver locates the septum of the port by palpation. Port access is accomplished by percutaneously inserting a needle, typically a non-coring needle, perpendicularly through the septum of the port and into the chamber. The drug or fluid is then administered by bolus injection or continuous infusion. Ordinarily the fluid flows through the chamber, into a catheter and finally to the site where the fluid is desired. Except for the septum, traditional ports are constructed from all-metal or all-plastic. Each type of construction has unique advantages and disadvantages.
All-metal constructions have the advantages that they maintain a septum in a self-sealing fashion after repeated percutaneous injections. Additionally, all-metal constructions, such as titanium, or stainless steel provide a port which is both biocompatible and compatible with the injected fluid.
However, all-metal constructions present the disadvantages that they are relatively heavy, difficult to fabricate and relatively expensive. Additionally, all-metal ports produce large Magnetic Resonance Imaging (MRI) artifacts. On the other hand, all-plastic ports have the advantages that they are inexpensive to construct, light in weight, and do not create an MRI artifact. However, ports constructed from plastic have the disadvantage that infused fluids may react with the plastic body of the port. All-plastic ports contain the disadvantage that they cannot maintain a sealing engagement with the septum after repeated percutaneous injections. Additionally, all-plastic ports are susceptible to nicks and scratches on the interior surface by the accessing needle. These nicks and scratches could lead to nidus, blood clots, or precipitation formations.
Efforts have been made to combine the advantages of all-metal ports with all-plastic ports. For example, in U.S. Pat. No. 4,802,885 to Weeks et al., a metal reservoir having a chamber sealed by a pre-formed silicone septum is jacketed by a single piece of a silicone elastomer. However, all-metal ports jacketed by a single piece of elastomer have significant shortcomings. These shortcomings include quality control problems during manufacturing, and expensive molding processes.
Other efforts have focused on providing a multiple piece all-plastic housing in cooperation with an open metal cup to sealingly engage a septum. For example, see U.S. Pat. No. 5,213,574 to Tucker. This design has shortcomings associated with it, including defects in the plastic housing which may cause an improperly sealed septum. Once the septum is improperly sealed the entire port must be discarded.
Therefore a need has arisen for an access port device which addresses the problems of prior port devices.
A variety of implantable devices, known as subcutaneous access ports, are utilized to deliver fluids to or to withdraw fluids from the bloodstream of a patient. Such access ports typically include a needle-impenetrable housing which encloses one or more fluid cavities and defines for each such fluid cavity an access aperture communicating through the housing on the side thereof which is adjacent to the skin of the patient when the access port is implanted in the body. A needle-penetrable septum is received in and seals each access aperture. Exit passageways located in an outlet stem communicate with each of the fluid cavities for dispensing medication therefrom to a predetermined location in the body of the patient through an implanted catheter attached to the access port.
Once the access port and the catheter have been implanted beneath the skin of a patient, quantities of medication or blood may be dispensed from one such fluid cavity by means of a non-coring needle passed through the skin of the patient and penetrating the septum into one of the respective fluid cavities. This medication is directed through the distal end of the catheter to an entry point into the venous system of the body of the patient.
Blood may also be withdrawn for sampling from the body of a patient through such an access port. This is accomplished by piercing the skin of the patient and one of the respective septums with a non-coring needle and applying negative pressure thereto. This causes blood to be drawn through the catheter into the fluid cavity corresponding to the pierced septum and then out of the body of the patient through the needle.
To prevent clotting thereafter, the withdrawal route is flushed with a saline solution or heparin using again a non-coring needle piercing the skin of the patient and the septum in the same manner as if a medication were being infused.
Both intermittent and continual injections of medication may be dispensed by the access port. Continual access involves the use of a non-coring needle attached to an ambulatory-type pump or a gravity feed IV bag suspended above the patient. The ambulatory-type pump or the IV bag continually feeds the medication or fluid through the needle to the fluid cavity in the access port and from there through the catheter to the entry point into the venous system.
To facilitate locating each respective septum once the access port has been implanted, some access ports incorporate a raised circular ring located about the outer perimeter of the septum. This raised ring enhances the tactile sensation afforded by the subcutaneous septum to the palpating fingertip of a medical practitioner. Alternatively, other access ports have utilized palpation ridges rather than a raised circular ring for substantially the same purpose. The palpation ridges allow the location of the septum to be accurately determined when the access port is subcutaneously implanted.
To preclude reaction with the tissues in the body of the patient, access ports are constructed of nonreactive materials, such as titanium or stainless steel. Although these materials are nonreactive, access ports constructed utilizing titanium or stainless steel materials produce an interfering or blurred image of the body of the patient in the vicinity of the implanted access port when diagnostic imaging techniques such as magnetic resonance imaging (“MRI”), CAT scans, or computerized tomography are used. The blurred region caused by the presence of a metallic access port in the body of a patient extends beyond the access port itself. Therefore, the use of metallic access ports limits the diagnostic imaging techniques that may be used relative to those areas of the body in which an access port is implanted. In place of metallic materials some access ports have been fabricated at least in part from biocompatible plastics.
A further problem relating to the materials for and manufacture of access ports is the deleterious impact of some manufacturing procedures on the fluids which flow through the fluid cavities and related structures located between the fluid cavities and the catheter. During the manufacture of an access port, whether the port is comprised of metallic or plastic materials, it becomes necessary to form the fluid cavities and exit passageways through which the fluid will be directed into the attached catheter. This manufacturing process often leaves sharp edges, seams and corners in the areas where the fluid cavity is to direct the flow of the fluid through an exit passageway. As blood or other fluids are injected through the septum into the fluid cavity, pressure developed within the fluid cavity tends to cause fluid to flow through the exit passageway. As the fluid in the fluid cavity flows past the sharp edges and corners produced in the manufacture of the access port, turbulence arises, taking the form of a vortex, adjacent to the sharp edges and corners. Some fluids, such as blood, are sensitive to this turbulence, and lysing of the red blood cell component of the injected blood can occur in these turbulent areas.
In addition, the production of the circular fluid cavities often results in the creation of areas within the housing in which fluid flow is retarded. These areas are referred to as dead spaces and usually occur in areas of transition, such as where the bottom of the septum interfaces with the walls of the fluid cavity and where the floor of the fluid cavity meets the exit passageway through which the fluid must flow. As the flow of fluids through dead spaces is retarded, stagnation occurs, resulting in some fluid being trapped within these dead spaces. If the access port is used to withdraw or transfuse blood, blood trapped in these dead spaces may form clots and block the flow of fluid through the fluid cavity.
Moreover, in some prior vascular access ports the internal reservoirs are formed by two plastic parts with are bonded together. This results in an undesirable seam being formed where the adjacent parts abut one another. The inside of the reservoir should be as smooth as possible to help prevent damage to blood cells or the initiation of blood clotting during infusion or withdrawal of blood through the port.
A further problem encountered in the design and construction of access port relates to the positioning of the septums within the housing of the access port. The positioning of the septums within the housing is a compromise between two conflicting objectives. These are the need to separate the septums to such a distance so that the septums may be easily differentiated for the purpose of injection and the need to restrict the overall dimensions of the access port for patient comfort and aesthetics. The distancing of the septums to facilitate their differentiation, however, results in a corresponding distancing of the fluid cavities. This result is at odds with another structural requirement for access ports with plural cavities, namely that the exit passageways from each fluid cavity be closely spaced at the point where the implanted catheter is to be coupled to the access port.
To guide the flow of a fluid from each of the spatially separated fluid cavities into the side-by-side configuration of fluid outflow necessitated by the dimensions of a plural lumen catheter, intermediate structural members have been required. Naturally, this complicates the process of manufacture and increases its cost, as well as the changes of structural failure.
There are several examples of such intermediate members used to resolve the manufacturing constraints imposed upon the construction of a passageway flowing from spatially separate fluid cavities into a side-by-side configuration acceptable by a catheter. One is to produce passageways in the form of bent metal tubes which are then insert molded or welded into the larger body of the access port. The use of such a metal component will interfere with the production of an access port which is free of limits as to the diagnostic imaging techniques that may be used relative to those areas of the body in which an access port is implanted. In addition, the integral nature of such metal outlet passageways raises the possibility of leakage of medication through the interstices between the metal tubes and the body of the access port.
Alternatively, to produce fluid flow from spatially separated fluid cavities into the closely spaced lumens of a catheter, each fluid cavity has been designated with its own spatially separated outlet stem. These outlet stems are then coupled by a hub structure for permanent attachment to the closely spaced lumens of a catheter. This type of arrangement increases the size of the overall access port and its cost of manufacture by adding thereto the necessity of fabricating and assembling of the hub element. Port connections to catheters in this manner are permanent. Accordingly, if the catheter is to be shortened by trimming, that trimming must occur at the distal end of the catheter, and this precludes the use of any type of specially designed tip or valve.
An additional set of problems encountered in the use of access ports relates to the actual connection of the catheter to the access port. This is most commonly effected by securing the catheter to an outlet stem protruding from the housing of the access port. In an attempt to lock the catheter to the outlet stem of the access port, thread-type systems have been developed wherein the catheter is attached to an outlet stem, and the outlet stem is then threaded into the access port. When utilizing this system, however, it is difficult to determine the amount of engagement of the catheter onto the outlet stem. Some catheter connection systems do not allow visual verification of attachment. As a result, leakage and failure can occur.
To overcome this problem, access ports are produced in which the catheter is pre-attached at the factory. While this practice alleviates many of the problems with leakage and failure due to catheter slippage, this system severely limits the type of the catheter usable with the access port. This precludes the use of catheters having specialized distal tips, as the distal end of the catheter is the only end that can then be trimmed to effect its ultimate sizing. For example, catheters utilizing a Groshong® slit valve at their distal end may not have any of the distal tip of the catheter removed without compromising the catheter.
Thus, there has been a need for an improved vascular access port which overcomes the above-noted problems, and which can be manufactured economically. The present invention fulfills these needs and provides other related advantages.
One aspect of the instant disclosure relates to access port for providing subcutaneous access to a patient. More particularly, an access port may comprise a body configured for capturing a septum for repeatedly inserting a needle therethrough into a cavity defined within the body. Further, the septum may include at least one topographical feature configured for identification of the septum. Also, a septum for an access port for providing subcutaneous access to a patient is encompassed by the instant disclosure, wherein the septum may comprise a body exhibiting at least one topographical feature configured for identification of the septum.
A further aspect of the instant disclosure relates to an access port for providing subcutaneous access to a patient including a body configured for capturing a septum for repeatedly inserting a needle therethrough into a cavity defined within the body, and a means for identification of the septum. In one embodiment, the means for identification may comprise at least one topographical feature of a surface of the septum. In another embodiment, means for identification may comprise a visually perceivable feature selected from the group consisting of: a color, a symbol, a letter, a pattern, and indicia. In a further embodiment, means for identification may comprise an x-ray detectable feature or an ultrasound detectable feature. In yet an additional embodiment, means for identification may comprise an RFID tag.
Another aspect of the instant disclosure relates to a method of identifying a subcutaneously implanted access port. More particularly, an access port including a septum may be provided. Further, at least one topographical feature of the septum of the access port may be perceived. In addition, the subcutaneously implanted access port may be identified in response to perceiving the at least one feature of the septum of the access port.
Features from any of the above mentioned embodiments may be used in combination with one another in accordance with the instant disclosure. In addition, other features and advantages of the instant disclosure will become apparent to those of ordinary skill in the art through consideration of the ensuing description, the accompanying drawings, and the appended claims.
Advantages of the instant disclosure will become apparent upon review of the following detailed description and drawings, which illustrate representations (not necessarily drawn to scale) of various aspects of the instant disclosure, wherein:
The septums 16 are formed with a generally circular shape, and, as shown in the drawings, may include a nipple 26 or a concave portion 28 on the outer surface thereof. The nipple is advantageous for visual and/or tactile location of the port device 10, and as a locator for needle insertion. Likewise, concave portion 28 provides similar features, but may be used in areas where a protruding nipple is undesirable. The septums 16A and 16B and housing 12 are preferably formed with mated tongue and groove portions, as shown in the side view drawings of
As opposed to plastic materials used in the prior art, the cup portion 14 is preferably formed of titanium or stainless steel to resist scratches and/or debris from being introduced into the chambers, as a result of needle impacts thereon. Preferably, cup 14A and 14B is attached to housing 12 via insert molding, interference fit, ultrasonic weld, biocompatible glue, and/or other attachment means.
FIGS. 4 and 5A-5B depict alternative embodiments for the cup member described above in
As discussed above, access ports may provide percutaneous access to a patient. In further detail, referring to
One aspect of the instant disclosure contemplates that a septum of an access port may include at least one perceivable or identifiable feature for identifying the septum and, optionally, the access port. Of course, the identifiable feature may be perceivable after the access port is implanted within a patient. For example, at least one or perhaps multiple identifiable feature(s) of a septum of an access port may be correlative to information (e.g., a manufacturer's model or design) pertaining to the access port. Thus, an identifiable feature from an access port of a particular model may be unique in relation to most, if not all, other identifiable features of another access port of a different model or design. Of course, the at least one identifiable feature of an access port may be further correlative with any information of interest, such as type of port (e.g., power-injectable port), catheter type, date of manufacture, material lots, part numbers, etc. In this way, once at least one identifiable feature of an access port is observed or otherwise determined, correlation of such at least one feature of an access port may be accomplished, and information pertaining to the access port may be obtained. Accordingly, “identification,” as used herein and in connection with a septum, means to provide the ability to correlate selected information of interest with a perceivable feature of a septum.
In one embodiment, at least one feature may be perceived by palpation (i.e., to examine by touch), by way of other physical interaction, or by visual observation. Accordingly, a person may touch or feel the septum of the access port to perceive at least one identifying characteristic of the septum. In another embodiment, at least one identifiable feature may be perceived via x-ray or ultrasound imaging. In yet a further embodiment, at least one identifiable feature may be perceived through magnetic, light, or radio energy interaction or communication with the septum.
Turning to the embodiment wherein at least one feature may be perceived through palpation, other physical interaction, or visual observation, a topography or exterior surface feature of a septum of an access port may be configured for perception. For example, the instant disclosure contemplates that a septum may include at least one topographical feature configured for identifying the access port after it is implanted. More particularly,
The instant disclosure further contemplates that a septum may include a plurality of protrusions that, collectively, are structured for perception and identification of the septum. For example,
As mentioned above, the instant disclosure contemplates that a septum may include at least one protrusion and that the protrusion may be configured, as desired, for perception and identification of the septum. For example, a protrusion extending from a surface of a septum may include at least one substantially planar surface.
As mentioned above, at least protrusion of a septum may be sized, shaped, and structured as desired. For example, in another embodiment, a septum may include at least one protrusion that is elongated. For example,
In a further aspect of the instant disclosure, a septum may include at least one recess that is structured for perception and identification of the septum. For example,
In another embodiment, a septum may include a plurality of recesses configured for perception (e.g., visual or by palpation) and identification of the septum. For example,
The instant disclosure also contemplates that at least one recess formed in a septum may comprise of at least one elongated recess. Thus, the instant disclosure contemplates that a septum may include at least one elongated recess configured for identifying the septum, an access part in which the septum is assembled, or both. For example,
In other embodiment contemplated by the instant disclosure, a septum may include at least one protrusion and at least one recess configured for perception and identification of the septum. For example,
The instant disclosure contemplates various configurations of a septum including at least one protrusion and at least one recess. For example,
Accordingly, the instant disclosure contemplates that at least one protrusion, protruding region, recess, recessed region, undulation, or adjacent features of different elevation may comprise a feature for identifying a septum of an access port. For example, in a further embodiment, a plurality of protrusions 80 may be spaced about a selected center or other point on a septum surface of a septum.
Further, in another embodiment, a topography of a septum may comprise elongated protrusions and elongated recesses.
It should also be understood that the instant disclosure contemplates access ports having a septum with an exposed surface defined, at least in part, by a periphery that is not circular in nature. Rather, the instant disclosure contemplates that an access port may have a periphery which is generally quadrilateral, generally rectangular, generally triangular, generally elliptical, generally oval, generally polygonal, or otherwise configured. It should also be understood from the discussion of the above-described various embodiments of a septum of an access port that variations, additions, combinations, or different features are encompassed by the instant disclosure. Thus, the instant disclosure is not limited to the above-described exemplary embodiments.
Generally, the instant disclosure contemplates that means for identifying a septum may be provided. In one embodiment, as described above, at least one topographical feature may comprise means for identifying a septum. In another embodiment, at least one visual feature may be perceived and used to identify a septum. For example, a color, a pattern, one or more letters, one or more numbers, symbols, any indicia, or combinations thereof, may be formed upon or as a portion of a septum. Such a configuration may allow for visual perception and identification of a septum. In addition, the instant disclosure also contemplates that at least one feature of an access port of the instant disclosure may not be observable visually or by palpation but, rather, may be otherwise observable. For example, means for identifying a septum may comprise at least one feature observable through interaction with an imaging technology such as x-ray or ultrasound. For instance, a metal feature (e.g., a plate or other metal geometry) may be included within a septum of an access port. As may be appreciated, such a metal feature may be represented on an x-ray generated by exposure of the access port to x-ray energy while simultaneously exposing x-ray sensitive film to x-ray energy passing through the access port. Further, the instant disclosure contemplates that a size, shape, or both size and shape of a metal feature of an access port may be configured for enhancing identification of an access port. For example, assuming that a metal feature comprises a metal plate, a size, shape, or both may be selectively tailored for identification of a septum. Similarly, a feature of an access port of the may be tailored for detection via ultrasound interaction. Such a feature may comprise an exterior topographical feature. In another embodiment, such a feature may comprise a composite structure including two or more materials that form an interface (i.e., an interior feature or surface) that may be identified by ultrasound imaging. In a further aspect of the instant disclosure, it is contemplated that a communicative technology may be utilized wherein information is encompassed by an access port of the instant disclosure. Generally, a communication device (e.g., a radio beacon, a light-emitting element, an ultrasound emitting transducer, etc.) may be imbedded or otherwise affixed to a septum of the instant disclosure. Such a communication device may be configured for transmitting information in response to a given impetus. More specifically, a septum may be exposed to a request signal (e.g., a sound, an impact or an acceleration, light, radio waves, etc.). Such a request signal may cause the communication device to transmit information therefrom via sound, light, radio waves, or as otherwise known in the art. Such information may be employed for identifying an access port of the instant disclosure. Thus, a wide variety of means for identifying a septum may be employed for identifying a septum.
In one exemplary example, radio frequency identification technology may be employed for identification of a septum of an access port. Particularly, so-called active RFID tags are powered by an internal battery and are typically read/write devices. Currently, a suitable cell coupled to suitable low power circuitry can ensure functionality for as long as ten or more years, depending upon the operating temperatures and read/write cycles and usage. So-called passive RFID tags operate without a separate external power source and obtain operating power generated from the reader. Passive RFID tags are typically programmed with a unique set of data (usually 32 to 128 bits) that cannot be modified. Read-only tags may operate as an identifier comparable to barcodes, which may contain selected product-specific information. Thus, passive RFID tags may be much lighter than active RFID tags, less expensive, and may offer a substantially unlimited operational lifetime. In one embodiment, an RFID tag may be affixed to an exterior surface of a septum. In another embodiment, an RFID tag may be imbedded within a septum. One advantage of RFID approach is the non-contact, non-line-of-sight nature of the technology. RFID tags can be read through a variety of visually and environmentally challenging conditions, where other optically related technologies may be less effective.
As will be appreciated by those skilled in the art, any septum configured according to the above described aspects of the instant disclosure may be incorporated within a housing or body to form an access port. For example,
In further detail,
While certain representative embodiments and details have been shown for purposes of illustrating aspects of the instant disclosure, it will be apparent to those skilled in the art that various changes in the methods and apparatus disclosed herein may be made without departing form the scope of the instant disclosure, which is defined in the appended claims. For example, other access port sizes and shapes may be employed; and various other embodiments and structures may be employed for forming at least one identifiable feature of an access port of the instant disclosure.
This application is a continuation-in-part of U.S. patent application Ser. No. 10/374,000, filed Feb. 25, 2003, now U.S. Pat. No. 7,713,251, which is a continuation of U.S. patent application Ser. No. 09/582,406, filed Jun. 23, 2000, now U.S. Pat. No. 6,527,754, which is the National Stage Of International Application No. PCT/US99/28695, filed Dec. 3, 1999, which claims the benefit of U.S. Provisional Patent Application No. 60/111,257, filed Dec. 7, 1998, the disclosure of each of which is incorporated, in its entirety, by this reference. This application claims the benefit of U.S. Provisional Patent Application No. 60/658,518, filed Mar. 4, 2005, the disclosure of which is incorporated, in its entirety, by this reference.
Number | Name | Date | Kind |
---|---|---|---|
574387 | Buckler | Jan 1897 | A |
611357 | Dembinski | Sep 1898 | A |
966696 | Merrill | Aug 1910 | A |
1713267 | Crowley | May 1929 | A |
2029553 | Bartschi et al. | Feb 1936 | A |
2433480 | Rendich | Dec 1947 | A |
2891689 | Gould | Jun 1959 | A |
D198453 | Weichselbaum | Jun 1964 | S |
3293663 | Cronin | Dec 1966 | A |
3341417 | Sinaiko | Sep 1967 | A |
3518428 | Ring | Jun 1970 | A |
3529633 | Vailancourt | Sep 1970 | A |
3643358 | Morderosian | Feb 1972 | A |
3829904 | Ling et al. | Aug 1974 | A |
3831583 | Edmunds, Jr. et al. | Aug 1974 | A |
3840009 | Michaels et al. | Oct 1974 | A |
3891997 | Herbert | Jul 1975 | A |
3915162 | Miller | Oct 1975 | A |
3919724 | Sanders et al. | Nov 1975 | A |
3922726 | Trentani et al. | Dec 1975 | A |
3951147 | Tucker et al. | Apr 1976 | A |
4027391 | Samis et al. | Jun 1977 | A |
4035653 | Karasko | Jul 1977 | A |
4121108 | Manor | Oct 1978 | A |
4123806 | Amstutz et al. | Nov 1978 | A |
4168586 | Samis | Sep 1979 | A |
4190040 | Schulte | Feb 1980 | A |
4190057 | Hill et al. | Feb 1980 | A |
4194122 | Mitchell et al. | Mar 1980 | A |
4202349 | Jones | May 1980 | A |
4222374 | Sampson et al. | Sep 1980 | A |
4233964 | Jefferts et al. | Nov 1980 | A |
4274006 | Caine | Jun 1981 | A |
4349498 | Ellis et al. | Sep 1982 | A |
4361153 | Slocum et al. | Nov 1982 | A |
4405305 | Stephen et al. | Sep 1983 | A |
4406567 | Samis et al. | Sep 1983 | A |
4425119 | Berglund | Jan 1984 | A |
4445896 | Gianturco | May 1984 | A |
4450592 | Niederer et al. | May 1984 | A |
4450985 | Beard | May 1984 | A |
4456011 | Warnecke et al. | Jun 1984 | A |
4469483 | Becker et al. | Sep 1984 | A |
4494545 | Slocum et al. | Jan 1985 | A |
4506676 | Duska | Mar 1985 | A |
4529635 | Sheldon | Jul 1985 | A |
4543088 | Bootman et al. | Sep 1985 | A |
4549879 | Groshong et al. | Oct 1985 | A |
4559046 | Groshong et al. | Dec 1985 | A |
4571749 | Fischell | Feb 1986 | A |
4576595 | Aas et al. | Mar 1986 | A |
4612877 | Hayes et al. | Sep 1986 | A |
4627844 | Schmitt | Dec 1986 | A |
4634427 | Hannula et al. | Jan 1987 | A |
4636194 | Schulte et al. | Jan 1987 | A |
4636213 | Pakiam | Jan 1987 | A |
4645495 | Vaillancourt | Feb 1987 | A |
4653508 | Cosman | Mar 1987 | A |
4655765 | Swift | Apr 1987 | A |
4657024 | Coneys | Apr 1987 | A |
4662652 | Hargis | May 1987 | A |
4668221 | Luther | May 1987 | A |
4671796 | Groshong et al. | Jun 1987 | A |
4673394 | Fenton, Jr. et al. | Jun 1987 | A |
4684365 | Reinicke | Aug 1987 | A |
4685447 | Iversen et al. | Aug 1987 | A |
4685905 | Jeanneret nee Aab | Aug 1987 | A |
4692146 | Hilger | Sep 1987 | A |
4695273 | Brown | Sep 1987 | A |
4697595 | Breyer et al. | Oct 1987 | A |
4701166 | Groshong et al. | Oct 1987 | A |
4704103 | Stober et al. | Nov 1987 | A |
4710174 | Moden et al. | Dec 1987 | A |
4718894 | Lazorthes | Jan 1988 | A |
4728894 | Yoda et al. | Mar 1988 | A |
4743231 | Kay et al. | May 1988 | A |
4753640 | Nichols et al. | Jun 1988 | A |
4755173 | Konopka et al. | Jul 1988 | A |
4760837 | Petit | Aug 1988 | A |
4762517 | McIntyre et al. | Aug 1988 | A |
4767410 | Moden et al. | Aug 1988 | A |
4772270 | Wiita et al. | Sep 1988 | A |
4772276 | Wiita et al. | Sep 1988 | A |
4773552 | Boege et al. | Sep 1988 | A |
4778452 | Moden et al. | Oct 1988 | A |
4781680 | Redmond et al. | Nov 1988 | A |
4781685 | Lehmann et al. | Nov 1988 | A |
4781695 | Dalton | Nov 1988 | A |
4802885 | Weeks et al. | Feb 1989 | A |
4804054 | Howson et al. | Feb 1989 | A |
4820273 | Reinicke | Apr 1989 | A |
4822341 | Colone | Apr 1989 | A |
4840615 | Hancock et al. | Jun 1989 | A |
4848346 | Crawford | Jul 1989 | A |
4857053 | Dalton | Aug 1989 | A |
4861341 | Woodburn | Aug 1989 | A |
4863470 | Carter | Sep 1989 | A |
4886501 | Johnston et al. | Dec 1989 | A |
4892518 | Cupp et al. | Jan 1990 | A |
4904241 | Bark | Feb 1990 | A |
4905709 | Bieganski et al. | Mar 1990 | A |
4909250 | Smith | Mar 1990 | A |
4915690 | Cone et al. | Apr 1990 | A |
4928298 | Tanaka et al. | May 1990 | A |
4929236 | Sampson | May 1990 | A |
4955861 | Enegren et al. | Sep 1990 | A |
4963133 | Whipple | Oct 1990 | A |
4966583 | Debbas | Oct 1990 | A |
4973319 | Melsky | Nov 1990 | A |
4983162 | Metais et al. | Jan 1991 | A |
5009644 | McDonald | Apr 1991 | A |
5013298 | Moden et al. | May 1991 | A |
5041098 | Loiterman et al. | Aug 1991 | A |
5044955 | Jagmin | Sep 1991 | A |
5045060 | Melsky et al. | Sep 1991 | A |
5045064 | Idriss | Sep 1991 | A |
5084015 | Moriuchi et al. | Jan 1992 | A |
5085216 | Henley, Jr. et al. | Feb 1992 | A |
5090066 | Schoepe et al. | Feb 1992 | A |
5092849 | Sampson | Mar 1992 | A |
5108317 | Beinhaur et al. | Apr 1992 | A |
5108377 | Cone et al. | Apr 1992 | A |
5112301 | Fenton, Jr. et al. | May 1992 | A |
5112303 | Pudenz et al. | May 1992 | A |
5129891 | Young | Jul 1992 | A |
5137529 | Watson et al. | Aug 1992 | A |
5147483 | Melsky et al. | Sep 1992 | A |
5152753 | Laguette et al. | Oct 1992 | A |
5156600 | Young | Oct 1992 | A |
5158547 | Doan et al. | Oct 1992 | A |
5167629 | Vertenstein et al. | Dec 1992 | A |
5167633 | Mann et al. | Dec 1992 | A |
5167638 | Felix et al. | Dec 1992 | A |
5171228 | McDonald | Dec 1992 | A |
5176653 | Metals et al. | Jan 1993 | A |
5176662 | Bartholomew et al. | Jan 1993 | A |
5178612 | Fenton, Jr. | Jan 1993 | A |
5185003 | Brethauer | Feb 1993 | A |
5189690 | Samuel | Feb 1993 | A |
5193106 | DeSena | Mar 1993 | A |
5195122 | Fabian | Mar 1993 | A |
5195123 | Clement | Mar 1993 | A |
5201715 | Masters | Apr 1993 | A |
5203771 | Melker et al. | Apr 1993 | A |
5203777 | Lee | Apr 1993 | A |
5213574 | Tucker | May 1993 | A |
5215537 | Lynn et al. | Jun 1993 | A |
5222499 | Allen et al. | Jun 1993 | A |
D337637 | Tucker | Jul 1993 | S |
5224938 | Fenton, Jr. | Jul 1993 | A |
5263930 | Ensminger | Nov 1993 | A |
5281205 | McPherson | Jan 1994 | A |
5290263 | Wigness et al. | Mar 1994 | A |
5295658 | Atkinson et al. | Mar 1994 | A |
5299253 | Wessels | Mar 1994 | A |
5309863 | Leeb, Jr. | May 1994 | A |
5312337 | Flaherty et al. | May 1994 | A |
5318545 | Tucker | Jun 1994 | A |
5320100 | Herweck et al. | Jun 1994 | A |
5328480 | Melker et al. | Jul 1994 | A |
5332398 | Miller et al. | Jul 1994 | A |
5336194 | Polaschegg et al. | Aug 1994 | A |
5338398 | Szwejkowski et al. | Aug 1994 | A |
5350360 | Ensminger et al. | Sep 1994 | A |
5352204 | Ensminger | Oct 1994 | A |
5360407 | Leonard et al. | Nov 1994 | A |
5383223 | Inokuchi et al. | Jan 1995 | A |
5383233 | Russell | Jan 1995 | A |
5383858 | Reilly et al. | Jan 1995 | A |
D355240 | Gladfelter et al. | Feb 1995 | S |
5387192 | Glantz et al. | Feb 1995 | A |
5394457 | Leibinger et al. | Feb 1995 | A |
5395324 | Hinrichs et al. | Mar 1995 | A |
5397329 | Allen | Mar 1995 | A |
5399168 | Wadsworth, Jr. et al. | Mar 1995 | A |
5405402 | Dye et al. | Apr 1995 | A |
5417565 | Long | May 1995 | A |
5417656 | Ensminger et al. | May 1995 | A |
5421814 | Geary | Jun 1995 | A |
5423334 | Jordan | Jun 1995 | A |
5425762 | Muller | Jun 1995 | A |
5456698 | Byland et al. | Oct 1995 | A |
5476460 | Montalvo | Dec 1995 | A |
5476880 | Cooke et al. | Dec 1995 | A |
5484402 | Saravia et al. | Jan 1996 | A |
5503630 | Ensminger et al. | Apr 1996 | A |
5507813 | Dowd et al. | Apr 1996 | A |
5509805 | Jagmin | Apr 1996 | A |
5513637 | Twiss et al. | May 1996 | A |
5514103 | Srisathapat et al. | May 1996 | A |
5520632 | Leveen et al. | May 1996 | A |
5527277 | Ensminger et al. | Jun 1996 | A |
5527307 | Srisathapat et al. | Jun 1996 | A |
5531684 | Ensminger et al. | Jul 1996 | A |
5556381 | Ensminger et al. | Sep 1996 | A |
5558641 | Glantz et al. | Sep 1996 | A |
5562617 | Finch, Jr. et al. | Oct 1996 | A |
5562618 | Cai et al. | Oct 1996 | A |
5575770 | Melsky et al. | Nov 1996 | A |
5607393 | Ensminger et al. | Mar 1997 | A |
5607407 | Tolkoff et al. | Mar 1997 | A |
5613945 | Cai et al. | Mar 1997 | A |
5620419 | Lui et al. | Apr 1997 | A |
5632729 | Cai et al. | May 1997 | A |
5637102 | Tolkoff et al. | Jun 1997 | A |
5638832 | Singer et al. | Jun 1997 | A |
5647855 | Trooskin | Jul 1997 | A |
5662612 | Niehoff | Sep 1997 | A |
5676146 | Scarborough | Oct 1997 | A |
5695490 | Flaherty et al. | Dec 1997 | A |
5702128 | Maxim et al. | Dec 1997 | A |
5702363 | Flaherty | Dec 1997 | A |
5704915 | Melsky et al. | Jan 1998 | A |
5709668 | Wacks | Jan 1998 | A |
5713844 | Peyman | Feb 1998 | A |
5713858 | Heruth et al. | Feb 1998 | A |
5713859 | Finch, Jr. et al. | Feb 1998 | A |
5718382 | Jaeger | Feb 1998 | A |
5718682 | Tucker | Feb 1998 | A |
5725507 | Petrick | Mar 1998 | A |
5733336 | Neuenfeldt et al. | Mar 1998 | A |
5733400 | Gore et al. | Mar 1998 | A |
5741228 | Lambrecht et al. | Apr 1998 | A |
5743873 | Cai et al. | Apr 1998 | A |
5743891 | Tolkoff et al. | Apr 1998 | A |
5746460 | Marohl et al. | May 1998 | A |
5758667 | Slettenmark | Jun 1998 | A |
5769823 | Otto | Jun 1998 | A |
5773552 | Hutchings et al. | Jun 1998 | A |
5776188 | Shepherd et al. | Jul 1998 | A |
5792104 | Speckman et al. | Aug 1998 | A |
5792116 | Berg et al. | Aug 1998 | A |
5810789 | Powers et al. | Sep 1998 | A |
5824071 | Nelson et al. | Oct 1998 | A |
5830172 | Leveen et al. | Nov 1998 | A |
5833654 | Powers et al. | Nov 1998 | A |
5835563 | Navab et al. | Nov 1998 | A |
5836935 | Ashton et al. | Nov 1998 | A |
5840063 | Flaherty | Nov 1998 | A |
5843069 | Butler et al. | Dec 1998 | A |
5853394 | Tolkoff et al. | Dec 1998 | A |
5868702 | Stevens et al. | Feb 1999 | A |
5882353 | VanBeek et al. | Mar 1999 | A |
5895424 | Steele, Sr. et al. | Apr 1999 | A |
5906596 | Tallarida | May 1999 | A |
5908414 | Otto et al. | Jun 1999 | A |
5913998 | Butler et al. | Jun 1999 | A |
5916263 | Goicoechea et al. | Jun 1999 | A |
5925017 | Kriesel et al. | Jul 1999 | A |
5925030 | Gross et al. | Jul 1999 | A |
5928197 | Niehoff | Jul 1999 | A |
5931829 | Burbank et al. | Aug 1999 | A |
5944023 | Johnson et al. | Aug 1999 | A |
5944688 | Lois | Aug 1999 | A |
5944712 | Frassica et al. | Aug 1999 | A |
5947953 | Ash et al. | Sep 1999 | A |
5951512 | Dalton | Sep 1999 | A |
5951522 | Rosato et al. | Sep 1999 | A |
5954687 | Baudino | Sep 1999 | A |
5957890 | Mann et al. | Sep 1999 | A |
5968011 | Larsen et al. | Oct 1999 | A |
5970162 | Kawashima et al. | Oct 1999 | A |
5989216 | Johnson et al. | Nov 1999 | A |
5989239 | Finch et al. | Nov 1999 | A |
5997524 | Burbank et al. | Dec 1999 | A |
6007516 | Burbank et al. | Dec 1999 | A |
6013051 | Nelson | Jan 2000 | A |
6013058 | Prosl et al. | Jan 2000 | A |
6017331 | Watts et al. | Jan 2000 | A |
6022335 | Ramadan | Feb 2000 | A |
6033389 | Cornish | Mar 2000 | A |
6039712 | Fogarty et al. | Mar 2000 | A |
6077756 | Lin et al. | Jun 2000 | A |
6086555 | Eliasen | Jul 2000 | A |
6090066 | Schnell | Jul 2000 | A |
6102884 | Squitieri | Aug 2000 | A |
6113572 | Gailey et al. | Sep 2000 | A |
6120492 | Finch et al. | Sep 2000 | A |
6161033 | Kuhn et al. | Dec 2000 | A |
6171198 | Lizama Troncoso et al. | Jan 2001 | B1 |
6171298 | Matsuura et al. | Jan 2001 | B1 |
6190352 | Haarala et al. | Feb 2001 | B1 |
6193684 | Burbank et al. | Feb 2001 | B1 |
6198807 | DeSena | Mar 2001 | B1 |
6203570 | Baeke | Mar 2001 | B1 |
6213973 | Eliasen et al. | Apr 2001 | B1 |
6228088 | Miller et al. | May 2001 | B1 |
6251059 | Apple et al. | Jun 2001 | B1 |
D445175 | Bertheas | Jul 2001 | S |
6269148 | Jessop et al. | Jul 2001 | B1 |
6287293 | Jones et al. | Sep 2001 | B1 |
6290677 | Arai et al. | Sep 2001 | B1 |
6305413 | Fischer et al. | Oct 2001 | B1 |
D450115 | Bertheas | Nov 2001 | S |
6332874 | Eliasen et al. | Dec 2001 | B1 |
6355021 | Nielsen et al. | Mar 2002 | B1 |
6356782 | Sirimanne et al. | Mar 2002 | B1 |
6361557 | Gittings et al. | Mar 2002 | B1 |
6398764 | Finch, Jr. et al. | Jun 2002 | B1 |
6419680 | Cosman et al. | Jul 2002 | B1 |
6450937 | Mercereau et al. | Sep 2002 | B1 |
6478783 | Moorehead | Nov 2002 | B1 |
6482217 | Pintor et al. | Nov 2002 | B1 |
6494867 | Elver et al. | Dec 2002 | B1 |
6497062 | Koopman et al. | Dec 2002 | B1 |
6500155 | Sasso | Dec 2002 | B2 |
6503228 | Li et al. | Jan 2003 | B1 |
6527754 | Tallarida et al. | Mar 2003 | B1 |
6537255 | Raines | Mar 2003 | B1 |
RE38074 | Recinella et al. | Apr 2003 | E |
6582418 | Verbeck et al. | Jun 2003 | B1 |
6613002 | Clark et al. | Sep 2003 | B1 |
6613662 | Wark et al. | Sep 2003 | B2 |
6626936 | Stinson | Sep 2003 | B2 |
6629950 | Levin | Oct 2003 | B1 |
6632217 | Harper et al. | Oct 2003 | B2 |
6652486 | Bialecki et al. | Nov 2003 | B2 |
6652503 | Bradley | Nov 2003 | B1 |
6676633 | Smith et al. | Jan 2004 | B2 |
6697664 | Kienzle, III et al. | Feb 2004 | B2 |
6705316 | Blythe et al. | Mar 2004 | B2 |
6719721 | Okazaki et al. | Apr 2004 | B1 |
6719739 | Verbeek et al. | Apr 2004 | B2 |
6738531 | Funahashi et al. | May 2004 | B1 |
6755842 | Kanner et al. | Jun 2004 | B2 |
6758841 | Haarala et al. | Jul 2004 | B2 |
6767356 | Kanner et al. | Jul 2004 | B2 |
6784783 | Scoggin et al. | Aug 2004 | B2 |
6826257 | Sayre et al. | Nov 2004 | B2 |
6852106 | Watson et al. | Feb 2005 | B2 |
6878136 | Fleury et al. | Apr 2005 | B2 |
6878137 | Benchetrit | Apr 2005 | B2 |
6949084 | Marggi et al. | Sep 2005 | B2 |
6962580 | Adams et al. | Nov 2005 | B2 |
6994315 | Ryan et al. | Feb 2006 | B2 |
6997914 | Smith et al. | Feb 2006 | B2 |
7008377 | Beane et al. | Mar 2006 | B2 |
7008412 | Maginot | Mar 2006 | B2 |
7016456 | Basu et al. | Mar 2006 | B2 |
7018361 | Gillespie, Jr. et al. | Mar 2006 | B2 |
7044942 | Jolly et al. | May 2006 | B2 |
7056316 | Burbank et al. | Jun 2006 | B1 |
7070591 | Adams et al. | Jul 2006 | B2 |
7072704 | Bucholz | Jul 2006 | B2 |
7074232 | Kanner et al. | Jul 2006 | B2 |
7083593 | Stultz | Aug 2006 | B2 |
7108686 | Burke et al. | Sep 2006 | B2 |
7123690 | Brown et al. | Oct 2006 | B1 |
7127040 | Sayre et al. | Oct 2006 | B2 |
7131962 | Estabrook et al. | Nov 2006 | B1 |
7140769 | Kay | Nov 2006 | B2 |
7191011 | Cantlon | Mar 2007 | B2 |
7198631 | Kanner et al. | Apr 2007 | B2 |
7214207 | Lynch et al. | May 2007 | B2 |
7214215 | Heinzerling et al. | May 2007 | B2 |
7223257 | Shubayev et al. | May 2007 | B2 |
7229417 | Foerster et al. | Jun 2007 | B2 |
7235067 | Morris et al. | Jun 2007 | B2 |
D546440 | Burnside | Jul 2007 | S |
7242982 | Singhal et al. | Jul 2007 | B2 |
7252469 | Zaluzec et al. | Aug 2007 | B2 |
7252649 | Sherry | Aug 2007 | B2 |
7261705 | Edoga et al. | Aug 2007 | B2 |
D554253 | Kornerup et al. | Oct 2007 | S |
7275682 | Excoffier et al. | Oct 2007 | B2 |
7276075 | Callas et al. | Oct 2007 | B1 |
D556153 | Burnside | Nov 2007 | S |
7306579 | Fujii | Dec 2007 | B2 |
7311702 | Tallarida et al. | Dec 2007 | B2 |
7318816 | Bobroff et al. | Jan 2008 | B2 |
7318818 | Yashiro et al. | Jan 2008 | B2 |
7322953 | Redinger | Jan 2008 | B2 |
D562442 | Blateri | Feb 2008 | S |
D562443 | Zinn et al. | Feb 2008 | S |
7331130 | Schweikert | Feb 2008 | B2 |
7331948 | Skarda | Feb 2008 | B2 |
7333013 | Berger | Feb 2008 | B2 |
D564449 | Dewberry | Mar 2008 | S |
7347838 | Kulli | Mar 2008 | B2 |
7347843 | Adams et al. | Mar 2008 | B2 |
7351233 | Parks | Apr 2008 | B2 |
7377915 | Rasmussen et al. | May 2008 | B2 |
D574950 | Zawacki et al. | Aug 2008 | S |
7413564 | Morris et al. | Aug 2008 | B2 |
D578203 | Bizup | Oct 2008 | S |
7445614 | Bunodiere et al. | Nov 2008 | B2 |
D582032 | Bizup et al. | Dec 2008 | S |
7465847 | Fabian | Dec 2008 | B2 |
D595892 | Smith et al. | Jul 2009 | S |
7563025 | Kay | Jul 2009 | B2 |
7713251 | Tallarida et al. | May 2010 | B2 |
7947022 | Amin et al. | May 2011 | B2 |
8029482 | Maniar et al. | Oct 2011 | B2 |
20010016717 | Haarala et al. | Aug 2001 | A1 |
20010051766 | Gazdzinski | Dec 2001 | A1 |
20010053889 | Marggi et al. | Dec 2001 | A1 |
20010056266 | Tallarida et al. | Dec 2001 | A1 |
20020095205 | Edwin et al. | Jul 2002 | A1 |
20020138068 | Watson et al. | Sep 2002 | A1 |
20020173769 | Gray et al. | Nov 2002 | A1 |
20030028173 | Forsberg | Feb 2003 | A1 |
20030130627 | Smith et al. | Jul 2003 | A1 |
20030139812 | Garcia et al. | Jul 2003 | A1 |
20030181878 | Tallarida et al. | Sep 2003 | A1 |
20030191452 | Meglin et al. | Oct 2003 | A1 |
20040020462 | Sauler et al. | Feb 2004 | A1 |
20040044306 | Lynch et al. | Mar 2004 | A1 |
20040054352 | Adams et al. | Mar 2004 | A1 |
20040056266 | Suh et al. | Mar 2004 | A1 |
20040064110 | Forsell | Apr 2004 | A1 |
20040073196 | Adams et al. | Apr 2004 | A1 |
20040106878 | Skujins et al. | Jun 2004 | A1 |
20040106891 | Langan et al. | Jun 2004 | A1 |
20040157952 | Soffiati et al. | Aug 2004 | A1 |
20040158207 | Hunn et al. | Aug 2004 | A1 |
20040167543 | Mazzocchi et al. | Aug 2004 | A1 |
20040176743 | Morris et al. | Sep 2004 | A1 |
20040199129 | DiMatteo | Oct 2004 | A1 |
20040199220 | Cantlon | Oct 2004 | A1 |
20040204692 | Eliasen | Oct 2004 | A1 |
20040225254 | Tanaka et al. | Nov 2004 | A1 |
20040254536 | Conlon et al. | Dec 2004 | A1 |
20040254537 | Conlon et al. | Dec 2004 | A1 |
20050049553 | Triplett et al. | Mar 2005 | A1 |
20050070875 | Kulessa | Mar 2005 | A1 |
20050075614 | Bunodiere et al. | Apr 2005 | A1 |
20050113806 | Murphree et al. | May 2005 | A1 |
20050131352 | Conlon et al. | Jun 2005 | A1 |
20050148866 | Gunderson | Jul 2005 | A1 |
20050148956 | Conlon et al. | Jul 2005 | A1 |
20050148957 | Girard et al. | Jul 2005 | A1 |
20050152841 | Sayre et al. | Jul 2005 | A1 |
20050171502 | Daly et al. | Aug 2005 | A1 |
20050182857 | Kong | Aug 2005 | A1 |
20050209573 | Brugger et al. | Sep 2005 | A1 |
20050215874 | Wang et al. | Sep 2005 | A1 |
20050241203 | Lizotte et al. | Nov 2005 | A1 |
20050256451 | Adams et al. | Nov 2005 | A1 |
20050256500 | Fujii | Nov 2005 | A1 |
20050277899 | Conlon et al. | Dec 2005 | A1 |
20050283119 | Uth et al. | Dec 2005 | A1 |
20060009788 | Freeman et al. | Jan 2006 | A1 |
20060017341 | Hahn et al. | Jan 2006 | A1 |
20060084929 | Eliasen | Apr 2006 | A1 |
20060089619 | Ginggen | Apr 2006 | A1 |
20060100592 | Eliasen | May 2006 | A1 |
20060116648 | Hamatake | Jun 2006 | A1 |
20060173410 | Moberg et al. | Aug 2006 | A1 |
20060173424 | Conlon | Aug 2006 | A1 |
20060178647 | Stats | Aug 2006 | A1 |
20060184141 | Smith et al. | Aug 2006 | A1 |
20060184142 | Schon et al. | Aug 2006 | A1 |
20060217359 | Wentworth et al. | Sep 2006 | A1 |
20060217659 | Patton | Sep 2006 | A1 |
20060224128 | Lurvey et al. | Oct 2006 | A1 |
20060224129 | Beasley et al. | Oct 2006 | A1 |
20060247584 | Sheetz et al. | Nov 2006 | A1 |
20060253076 | Butts et al. | Nov 2006 | A1 |
20060264898 | Beasley et al. | Nov 2006 | A1 |
20070007839 | Lin | Jan 2007 | A1 |
20070049876 | Patton | Mar 2007 | A1 |
20070055290 | Lober | Mar 2007 | A1 |
20070073250 | Schneiter | Mar 2007 | A1 |
20070078391 | Wortley et al. | Apr 2007 | A1 |
20070078416 | Eliasen | Apr 2007 | A1 |
20070078432 | Halseth et al. | Apr 2007 | A1 |
20070083156 | Muto et al. | Apr 2007 | A1 |
20070149920 | Michels et al. | Jun 2007 | A1 |
20070149921 | Michels et al. | Jun 2007 | A1 |
20070161958 | Glenn | Jul 2007 | A1 |
20070179456 | Glenn | Aug 2007 | A1 |
20070185462 | Byrum | Aug 2007 | A1 |
20070191773 | Wojcik | Aug 2007 | A1 |
20070208313 | Conlon et al. | Sep 2007 | A1 |
20070219510 | Zinn et al. | Sep 2007 | A1 |
20070233017 | Zinn et al. | Oct 2007 | A1 |
20070233018 | Bizup et al. | Oct 2007 | A1 |
20070255234 | Haase et al. | Nov 2007 | A1 |
20070270691 | Bailey et al. | Nov 2007 | A1 |
20070270770 | Bizup | Nov 2007 | A1 |
20070276344 | Bizup et al. | Nov 2007 | A1 |
20070299408 | Alferness et al. | Dec 2007 | A1 |
20080004642 | Birk et al. | Jan 2008 | A1 |
20080008654 | Clarke et al. | Jan 2008 | A1 |
20080015701 | Garcia et al. | Jan 2008 | A1 |
20080039820 | Sommers et al. | Feb 2008 | A1 |
20080048855 | Berger | Feb 2008 | A1 |
20080114308 | di Palma et al. | May 2008 | A1 |
20080138387 | Machiraju | Jun 2008 | A1 |
20080140025 | Sheetz et al. | Jun 2008 | A1 |
20080208236 | Hobbs et al. | Aug 2008 | A1 |
20080281279 | Hoendervoogt et al. | Nov 2008 | A1 |
20080319398 | Bizup | Dec 2008 | A1 |
20080319399 | Schweikert et al. | Dec 2008 | A1 |
20080319405 | Bizup | Dec 2008 | A1 |
20090024024 | Zinn | Jan 2009 | A1 |
20090024098 | Bizup et al. | Jan 2009 | A1 |
20090035582 | Nakatani et al. | Feb 2009 | A1 |
20090118683 | Hanson et al. | May 2009 | A1 |
20090156928 | Evans et al. | Jun 2009 | A1 |
20090204072 | Amin et al. | Aug 2009 | A1 |
20090204074 | Powers et al. | Aug 2009 | A1 |
20090221976 | Linden | Sep 2009 | A1 |
20090227862 | Smith et al. | Sep 2009 | A1 |
20090227951 | Powers et al. | Sep 2009 | A1 |
20100042073 | Oster et al. | Feb 2010 | A1 |
20100069743 | Sheetz et al. | Mar 2010 | A1 |
Number | Date | Country |
---|---|---|
0619101 | Oct 1994 | EP |
0619101 | Oct 1994 | EP |
2006025948 | Feb 2006 | JP |
WO-8600213 | Jan 1986 | WO |
WO-9305730 | Apr 1993 | WO |
WO 9701370 | Jan 1997 | WO |
WO-9701370 | Jan 1997 | WO |
WO-9706845 | Feb 1997 | WO |
WO-9817337 | Apr 1998 | WO |
WO9942166 | Aug 1999 | WO |
WO-0033901 | Jun 2000 | WO |
WO-0247549 | Jun 2002 | WO |
WO-0247549 | Jun 2002 | WO |
WO2004004800 | Jan 2004 | WO |
2004071555 | Aug 2004 | WO |
2004091434 | Oct 2004 | WO |
2005037055 | Apr 2005 | WO |
2006078915 | Jul 2006 | WO |
WO-2006096686 | Sep 2006 | WO |
WO-2006116438 | Nov 2006 | WO |
2006130133 | Dec 2006 | WO |
WO-2006134100 | Dec 2006 | WO |
WO2007136538 | May 2007 | WO |
WO 2007079024 | Jul 2007 | WO |
WO-2007094898 | Aug 2007 | WO |
WO-2007092210 | Aug 2007 | WO |
2007109164 | Sep 2007 | WO |
WO-2007098771 | Sep 2007 | WO |
2007126645 | Nov 2007 | WO |
WO 2008008126 | Jan 2008 | WO |
WO-2008019236 | Feb 2008 | WO |
WO-2008048361 | Apr 2008 | WO |
WO-2008063226 | May 2008 | WO |
2008147760 | Dec 2008 | WO |
2009002839 | Dec 2008 | WO |
WO-2008157763 | Dec 2008 | WO |
WO-2009012385 | Jan 2009 | WO |
WO-2009012395 | Jan 2009 | WO |
WO-2009035582 | Mar 2009 | WO |
WO-2009035582 | Mar 2009 | WO |
2009046725 | Apr 2009 | WO |
WO-2009046439 | Apr 2009 | WO |
WO-2009046439 | Apr 2009 | WO |
2009108669 | Sep 2009 | WO |
Number | Date | Country | |
---|---|---|---|
20060224129 A1 | Oct 2006 | US |
Number | Date | Country | |
---|---|---|---|
60111257 | Dec 1998 | US | |
60658518 | Mar 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09582406 | US | |
Child | 10374000 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10374000 | Feb 2003 | US |
Child | 11320223 | US |